Krsnaa Diagnostics Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹222(23.27%)
Premium (ELP)
Krsnaa Diagnostics Limited's successfully transitioned to public market status with its listing on NSE, BSE on Aug 16, 2021. The IPO mobilized 1,27,31,605 Shares in cumulative capital, including 42,06,085 Shares for corporate expansion and ₹812.00 Cr for shareholder liquidity management.
The public offering was conducted within the price parameters of ₹933 to ₹954, with minimum investment lots of 15 shares. subscription activity between Aug 04, 2021 and Aug 06, 2021 demonstrated market reception to the company's valuation and growth narrative.
The allotment process concluded on Aug 12, 2021, finalizing share distribution to successful bidders. The listing represents a transformational event, providing the company with enhanced market visibility, regulatory compliance framework, and access to diversified investor capital.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 2010, Krsnaa Diagnostics Ltd is one of India’s fastest-growing diagnostic chains, offering a wide range of services including imaging/radiology (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology to hospitals, medical colleges, and community health centres. The company has a strong presence in non-metro and lower-tier cities, operating 1,801 diagnostic centres across 13 cities as of December 31, 2020. In fiscal 2020, Krsnaa Diagnostics served approximately 5.27 million patients.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Differentiated Provider: Offers unique diagnostic services in India.
- Comprehensive Services: Covers imaging, pathology, and more.
- Strong Brand: Recognized for quality healthcare at affordable prices.
- Wide Market Presence: Operations across 13 states in India.
- Consistent Financials: Demonstrates a stable track record of performance.
NA
- Rajendra Mutha
Krsnaa Diagnostics Limited
Kfin Technologies Limited